Mainstay Medical: $108M raised by Mainstay Medical to support US launch of back pain implant
Mainstay Medical raised $108 million to fund the launch of its ReActiv8 implant in the U.S. and pursue post-market clinical studies.
Read full article »
Mainstay is an Ireland-based medical device company that develops implantable restorative neurostimulation devices for the treatment of chronic low back pain.
Read more